![]() |
市场调查报告书
商品编码
1129242
全球毛髮角化病治疗市场 - 2022-2029Global Keratosis Pilaris Treatment Market - 2022-2029 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计毛髮角化病治疗的进展将推动市场增长。
二氧化氯化合物具有优良的抗菌消炎作用,对人体无害。它是一种高浓度的危险气体。然而,当它溶解在水中并施用于人体组织时,它会被细胞内的防御机制灭活,不会引起任何不良反应。已发现它是治疗毛髮角化病的有效清洁剂。此外,它通过中和活性氧并破坏稳定角蛋白的分子内和分子间二硫键而起到角质层分离剂的作用。它只与一些特定的氨基酸发生反应,不氧化脂质和碳水化合物等有机化合物。活性氨基酸有半胱氨酸、酪氨酸、色氨酸、蛋氨酸、脯氨酸、羟脯氨酸、组氨酸等,其生物作用大部分由半胱氨酸、蛋氨酸、酪氨酸和色氨酸组成。因此,作为毛髮角化病的治疗剂的需求不断增加。综上所述,未来毛髮角化症治疗药物的市场规模有望扩大。
与毛髮角化病治疗相关的并发症预计将阻碍市场增长。
患者经常对疾病的外观感到苦恼。患者创伤性地破坏病变导致的疤痕是另一个可能发生的问题。缺乏对使用规定的局部治疗和不操纵病变的重要性的认识是预计在预测期内阻碍市场的一些因素。
全球角化病支柱治疗市场 - 行业分析
毛髮角化病治疗市场基于波特五力、供应链分析、报销方案、产品创新和定价分析等各种行业因素对市场进行了深入分析。
COVID-19 影响分析
COVID-19 大流行对医疗保健系统和市场产生了适度影响。与 SARS-CoV-2 相关的皮肤病在全球范围内呈上升趋势。黄斑疹、水疱疹、假性紫癜、毛髮角化病和荨麻疹是与这些疾病相关的五种主要模式。此外,到 2020 年,由于对非必要的医生就诊的限制和大多数国家的全面封锁,诊断和治疗率将急剧下降。美国皮肤病学会也一直在与皮肤科医生保持沟通,以限制对患有非紧急医疗问题(如毛髮角化病)的患者的访问。
此外,大流行还将扰乱供应炼和流程。许多公司将转移到其他地区以确保产品可用性并保护其供应链。因此,从上面这句话来看,市场受到了影响,预计随着经济活动的恢復,市场将迅速获得牵引力。
全球毛髮角化病治疗市场报告将提供对大约 45 多个市场数据表、40 多个数字和 160 页的访问。
Keratosis Pilaris Treatment market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 4.3 % during the forecast period (2022-2029).
Keratosis pilaris is a common skin ailment that causes small bumps on your arms, legs, or buttocks. Bumps form when there is too much keratin in your skin. Moisturizers and prescription creams are used to assist and improve the appearance of the skin. By the age of 30, the problem normally goes away.
Advancement in the treatment of Keratosis Pilaris is expected to drive market growth.
Chlorine dioxide compound is a great antibacterial and anti-inflammatory substance that is non-toxic to humans. It's a dangerous gas at high concentrations. Still, when it's dissolved in water and administered to human tissue, it's inactivated by an intracellular defense mechanism, so there are no adverse effects. In keratosis pilaris, it has been discovered to be an effective cleansing agent. Moreover, it functions as a keratolytic by neutralizing reactive oxygen molecules and destroying the intramolecular and intermolecular disulfide bonds that stabilize keratin. It only reacts with a few specific amino acids and does not oxidize lipids, carbohydrates, or other organic compounds. Cysteine, tyrosine, tryptophan, methionine, proline, hydroxyproline, and histidine are among the amino acids it reacts with, with cysteine, methionine, tyrosine, and tryptophan constituting the majority of its biologic action. Therefore, there is an increased demand for the treatment of Keratosis Pilaris. Thus, from the above statements, the market is expected to drive in the forecast period.
Complications associated with Keratosis Pilaris Treatment are expected to hamper the market growth.
Patients are often distressed about the cosmetic appearance of the condition. Scarring resulting from the patient rupturing the lesions traumatically is another problem that might occur. Lack of awareness about the importance of using the prescribed topical treatments and not manipulating the lesions are some factors the market is expected to hamper in the forecast period.
Global Keratosis Pilaris Treatment Market - Industry Analysis
The keratosis pilaris treatment market provides in-depth analysis of the market based on various industry factors such as porter's five forces, supply chain analysis, reimbursement scenario, product innovation, pricing analysis, etc.
COVID-19 Impact Analysis
The COVID-19 pandemic has moderately impacted healthcare systems and the market. SARS-CoV-2-related cutaneous diseases have been on the rise all over the world. Maculopapular rash, vesicular rash, pseudo-chilblain, keratosis pilaris, and urticaria are the five most common patterns associated with these disorders. Moreover, due to limits on non-essential doctor visits and complete lockdown in most countries, diagnosis and treatment rates have decreased dramatically by 2020. In addition, the American Academy of Dermatology was in constant contact with dermatologists to limit the number of patients with non-urgent medical concerns, such as keratosis pilaris, who were allowed to visit.
Additionally, the pandemic interrupts the supply chain and process. Many companies will vary to other geographic regions to ensure that products remain available and protect their supply chain. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of the economic activities.
Topical Exfoliates segment is expected to hold the largest market share in keratosis pilaris treatment market
The topical exfoliates segment is expected to dominate in 2021. The segment is beneficial because Keratosis pilaris normally disappears on its own over time. In the interim, you can improve the appearance of your skin using any of the many products available. If moisturizing and other self-care measures don't help, your doctor may prescribe medicated creams. For instance, Alpha hydroxy acid, lactic acid, salicylic acid, and urea-containing creams help loosen and eliminate dead skin cells. They also soften and hydrate dry skin. These creams (topical exfoliants) are available over-the-counter or with a prescription, depending on their intensity.
Moreover, the use of a medicated cream daily may help to improve the appearance of the skin. If you stop, though, the problem will return. Keratosis pilaris can linger for years, even after treatment. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.
North America region holds the largest market share in the global keratosis pilaris Treatment market
In 2021, North America accounted for the highest revenue share. The increasing prevalence of Keratosis Pilaris, rising patient education among the population, advancement in the treatment of Keratosis Pilaris, high rate of adoption of solutions, increase in the number of patients with keratosis pilaris visiting the doctor, as well as new players are focusing on forming partnerships with pharmacies are some of the factors the market is expected to boost in the forecast period. For instance, The appropriate management of keratosis pilaris necessitates patient education. Patients must recognize that keratosis pilaris is a chronic illness with no cure. The physician should also inform the patient that the illness often improves without therapy over time and that treatments are purely cosmetic. Patients must understand that keratosis pilaris is frequently resistant to treatment methods.
Moreover, Keratosis pilaris causes discoloration, which can be improved with laser treatments. Laser treatments are performed by dermatologists who use a laser to target the skin. It's sometimes used to alleviate extreme inflammation and redness. It's not a cure, but it might help when creams and lotions aren't cutting it. This treatment requires numerous sessions to be effective. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.
Major key players in the keratosis pilaris treatment market are Neostrata Company, Inc., SLMD Skincare, Galderma, Touch Skin Care, Nip + Fab, Neutrogena, Eucerin, AmLactin, CeraVe, First Aid Beauty.
NeoStrata Company, Inc., located in Princeton, NJ, develops and markets a comprehensive range of clinically proven, dermatologist-developed skincare brands, including NeoStrata, Exuviance, CoverBlend, NeoCeuticals and NeoStrata Therapeutics. Polyhydroxy Acid technology is used in the company's innovative therapeutic and aesthetic dermatological solutions to fulfill the needs of all skin types. They're sold at consumer stores, doctors' clinics, and spas worldwide. Moreover, AHAs are advantageous in treating dermatological diseases and efficient in spurring prematurely aged or damaged skin to regenerate itself, revolutionizing the treatment of aging skin, according to the company's passion and vision.
GLYCOLIC RENEWAL SERUM: This potent blend of 10% Alpha Hydroxy Acid (AHA) and antioxidants is designed to improve the texture of the skin's surface. Glycolic Acid is formulated to promote surface skin cells' exfoliation while keeping the pH at a healthy level.
The global keratosis pilaris treatment market report would provide an access to an approx. 45+market data table, 40+figures and 160pages.
LIST NOT EXHAUSTIVE